martes, 7 de enero de 2020

TB Notes 4, 2019 | Newsletters | Publications & Products | TB | CDC

TB Notes 4, 2019 | Newsletters | Publications & Products | TB | CDC



New Drug-Resistant TB Treatment Guidelines
MDR Guidelines
The new guidelines provide recommendations for treating multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB), as well as isoniazid-resistant TB. The recommendations prioritize orally-administered medications to make treatment more tolerable and improve patient outcomes, and provide guidance on the choice and number of drugs to use during treatment. Importantly, the recommendations address treatment of contacts to drug-resistant TB cases to prevent future drug-resistant TB disease. Recommendations also cover treatment length, the role of surgery, practices for treating special populations, and monitoring treatment.
CDC offers resources to help raise awareness of drug-resistant TB, including personal stories of MDR TB survivors like Nauman and Tenzininfographicspdf icon, and the latest U.S. drug-resistant TB data.

No hay comentarios:

Publicar un comentario